花旗发表研究报告指，石药集团(01093.HK) 上半年收入按年跌18.5%，纯利跌15.6%，逊于该行及市场预期；毛利降至65.6%；销售开支显著减少，按年减少36%至30亿元人民币。管理层预期，下半年的产品销售将较上半年录得增长，并料下半年达成另外两项BD合作，而每笔交易金额将超过50亿美元。该行下调石药2025至2027年的收入预测13%、11%及9%，以反映销售趋势，并降集团每股盈测10%...
Source Link花旗发表研究报告指，石药集团(01093.HK) 上半年收入按年跌18.5%，纯利跌15.6%，逊于该行及市场预期；毛利降至65.6%；销售开支显著减少，按年减少36%至30亿元人民币。管理层预期，下半年的产品销售将较上半年录得增长，并料下半年达成另外两项BD合作，而每笔交易金额将超过50亿美元。该行下调石药2025至2027年的收入预测13%、11%及9%，以反映销售趋势，并降集团每股盈测10%...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.